E. Ohman J:or Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

E. Ohman J:or Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,500	Closed	-$1.93M	–	486
2021 Q2	$1.93M	Buy	10,500 +600	+6%	+$103K	0.06%	186
2021 Q1	$1.51M	Buy	9,900 +300	+3%	+$46.4K	0.05%	197
2020 Q4	$1.5M	Hold	9,600	–	–	0.06%	176
2020 Q3	$1.1M	Buy	9,600 +1,500	+19%	+$162K	0.05%	172
2020 Q2	$909K	Sell	8,100 -207,050	-96%	-$22M	0.05%	173
2020 Q1	$19.3M	Buy	215,150 +203,050	+1,678%	+$19.9M	1.42%	21
2019 Q4	$1.31M	Buy	+12,100	New	+$1.29M	0.07%	159
2018 Q2	–	Sell	-5,100	Closed	-$568K	–	549
2018 Q1	$568K	Hold	5,100	–	–	0.05%	226
2017 Q4	$610K	Sell	5,100 -1,200	-19%	-$146K	0.05%	225
2017 Q3	$884K	Hold	6,300	–	–	0.08%	170
2017 Q2	$767K	Hold	6,300	–	–	0.08%	178
2017 Q1	$764K	Buy	6,300 +1,100	+21%	+$142K	0.09%	181
2016 Q4	$636K	Buy	5,200 +700	+16%	+$85.7K	0.09%	176
2016 Q3	$551K	Hold	4,500	–	–	0.08%	181
2016 Q2	$525K	Hold	4,500	–	–	0.09%	170
2016 Q1	$626K	Hold	4,500	–	–	0.11%	140
2015 Q4	$858K	Hold	4,500	–	–	0.15%	117
2015 Q3	$704K	Hold	4,500	–	–	0.19%	112
2015 Q2	$813K	Hold	4,500	–	–	0.19%	115
2015 Q1	$780K	Hold	4,500	–	–	0.18%	116
2014 Q4	$832K	Hold	4,500	–	–	0.2%	109
2014 Q3	$746K	Hold	4,500	–	–	0.18%	115
2014 Q2	$703K	Hold	4,500	–	–	0.17%	131
2014 Q1	$685K	Hold	4,500	–	–	0.17%	125
2013 Q4	$597K	Sell	4,500 -800	-15%	-$96K	0.14%	152
2013 Q3	$616K	Hold	5,300	–	–	0.16%	139
2013 Q2	$489K	Buy	+5,300	New	+$511K	0.13%	164

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

E. Ohman J:or Asset Management's ALXN Position: Q3 2021 in Review

E. Ohman J:or Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 10,500 shares — an estimated $1.93M sold.

E. Ohman J:or Asset Management first reported a position in ALXN in Q2 2013 and held it in 27 quarters. The position peaked at $19.3M in Q1 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

E. Ohman J:or Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
E. Ohman J:or Asset Management sold 10,500 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.93M.
E. Ohman J:or Asset Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 27 quarters.
E. Ohman J:or Asset Management's Alexion Pharmaceuticals position peaked at $19.3M in Q1 2020.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on E. Ohman J:or Asset Management's 13F filing for Q3 2021, filed 5 Apr 2024.